Increased Frequency of the Chemokine Receptor CCR2 on Circulating CD19+CD5+ Lymphocytes in Therapy‐Naïve CLL Patients With the Detectable EBV DNA and High‐Avidity Antibodies Against the EBV Capsid Antigen
Laura Zvejniece, Svetlana Kozireva, Mariia Nazarenko, Olga Kornilova, Alla Rivkina, Sandra Lejniece, Ainars Leonciks, Modra Murovska, Elena Kashuba, Irina Kholodnyuk · 2026
Read Increased Frequency of the Chemokine Receptor CCR2 on Circulating CD19+CD5+ Lymphocytes in Therapy‐Naïve CLL Patients With the Detectable EBV DNA and High‐Avidity Antibodies Against the EBV Capsid Antigen by Laura Zvejniece, Svetlana Kozireva, Mariia Nazarenko, Olga Kornilova, Alla Rivkina, Sandra Lejniece, Ainars Leonciks, Modra Murovska, Elena Kashuba, Irina Kholodnyuk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13463309.txt.
Description
A peer-reviewed research article from Europe PMC (2026). High EBV load in peripheral blood (PB) of untreated patients with chronic lymphocytic leukemia (CLL) has been associated with shorter overall survival. We demonstrated previously that EBV infection of B cells upregulates CCR1 and CCR2.
Catalog record
| CREATOR | Laura Zvejniece, Svetlana Kozireva, Mariia Nazarenko, Olga Kornilova, Alla Rivkina, Sandra Lejniece, Ainars Leonciks, Modra Murovska, Elena Kashuba, Irina Kholodnyuk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |